SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In
 
We’re going down soon, to move to a new Data Center today.  We’ll be up ASAP.  Sorry.

Curaxis Pharmaceutical Corp – IPO: ‘S-1’ on 9/8/05 – EX-21.1

On:  Thursday, 9/8/05, at 7:20pm ET   ·   As of:  9/9/05   ·   Accession #:  1193125-5-182448   ·   File #:  333-128193

Previous ‘S-1’:  None   ·   Next:  ‘S-1/A’ on 10/13/05   ·   Latest:  ‘S-1/A’ on 12/8/05

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/09/05  Curaxis Pharmaceutical Corp       S-1         9/08/05   19:2.9M                                   RR Donnelley/FA

Initial Public Offering (IPO):  Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   1.18M 
 2: EX-3.1      Amended and Restated Certificate of Incorporation   HTML     71K 
                          of the Registrant                                      
 3: EX-3.2      By-Laws of the Registrant                           HTML    106K 
 4: EX-10.1     2001 Stock Option/Stock Issuance Plan               HTML     46K 
10: EX-10.10    Master Services Agreement                           HTML    143K 
11: EX-10.11    Employment Agreement Between the Registrant and     HTML     28K 
                          Sheldon Goldberg                                       
12: EX-10.12    Offer Letter Dated August 20, 2004                  HTML     14K 
13: EX-10.13    Contract for Sale and Purchase of Real Property     HTML     46K 
 5: EX-10.2     2005 Stock Option Plan                              HTML     46K 
 6: EX-10.6     Lease Agreement, Dated 1/1/02 Between the           HTML    313K 
                          Registrant and Colonnade Development                   
 7: EX-10.7     Sublease Agreement, Dated 5/30/05, Between the      HTML     74K 
                          Registrant and Salix Pharm.                            
 8: EX-10.8     Lease Agreement, Dated 10/4/04, Between the         HTML    147K 
                          Registrant and Are-7030 Kit Creek                      
 9: EX-10.9     Feasibility, Development and Commercialization      HTML    204K 
                          Agreement                                              
14: EX-21.1     Subsidiaries of the Registrant                      HTML      7K 
15: EX-23.1     Consent of Pricewaterhousecoopers LLP               HTML      9K 
16: EX-23.3     Consent of James D. Artman                          HTML      9K 
17: EX-23.4     Consent of William E. McConville                    HTML      9K 
18: EX-23.5     Consent of Tommy G. Thompson                        HTML      9K 
19: EX-23.6     Consent of Michael Reagan                           HTML      9K 


EX-21.1   —   Subsidiaries of the Registrant


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Subsidiaries of the Registrant  

Exhibit 21.1

 

List of Subsidiaries

 

None.

 

Top
Filing Submission 0001193125-05-182448   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 11, 11:18:30.1am ET